Impact of mitral regurgitation on left ventricular remodeling and function in children with rheumatic heart disease

Adrian J Tarca1, Louise E Causer1, Katie L Maslin1

  • 1Department of Paediatric Cardiology, Children's Cardiac Centre, Perth Children's Hospital, Perth, WA, 6009, Australia.

Insights

Pediatric rheumatic heart disease (RHD) patients undergoing mitral valve surgery experience persistent left ventricular enlargement and reduced function post-operation. Pre-operative left ventricular volumes predict post-operative dysfunction, suggesting timing of intervention is crucial.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiac Surgery

Background:

  • Rheumatic heart disease (RHD) is a significant cause of acquired heart disease in children globally.
  • Mitral regurgitation (MR) in pediatric RHD can lead to left ventricular (LV) remodeling and dysfunction.
  • The long-term impact of mitral valve (MV) surgery on LV mechanics in pediatric RHD is not fully understood.

Purpose of the Study:

  • To investigate the effects of MV surgery on myocardial mechanics, LV remodeling, and function in pediatric RHD patients.
  • To identify pre-operative predictors of post-operative LV dysfunction.
  • To inform optimal timing for surgical intervention in pediatric RHD with MR.

Main Methods:

  • Retrospective review of echocardiographic data from 18 pediatric RHD patients who underwent MV surgery.
  • Comparison of pre-operative and mid-term post-operative echocardiograms with age-matched controls.
  • Analysis of LV end-diastolic indexed volumes (LVEDVi), LV ejection fraction (LVEF), and global longitudinal strain (GLS).

Main Results:

  • Pediatric RHD patients had persistently larger LVEDVi compared to controls, both pre- and post-operatively.
  • Post-operative LVEF and GLS significantly decreased at mid-term follow-up compared to pre-operative values.
  • Pre-operative LVEDVi (≥102 ml/m2) was a significant predictor of post-operative LV dysfunction (LVEF <55%) and negatively correlated with GLS.

Conclusions:

  • Surgical alleviation of MR in pediatric RHD does not reverse LV enlargement and is associated with mid-term LV functional decline.
  • Pre-operative LVEDVi is a key predictor of post-operative LV dysfunction.
  • Consideration of pre-operative LV indexed volumes in surgical planning may improve outcomes; further research on timely intervention is warranted.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
28
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
69
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
35
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
31